Moderate Bleeding in Cardiac Surgery Post Operative

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

303 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-03-11

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Determine a bleeding threshold by measuring the blood volume in ml / kg / h collected in the drainage system to define moderate bleeding postoperative cardiac surgery and define the population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SvO2 Trigger in Transfusion Strategy After Cardiac Surgery

NCT02761564

Undergoing Nonemergent Cardiac Surgery Central Venous Catheter on the Superior Vena Cava (to Perform ScVO2 Measure) Anemia (<9g/dL) Requiring Blood Transfusion +2 more

COMPLETED NA

Erythrocyte Transfusion Based on the Measurement of Central Venous Oxygen Saturation in Postoperative Cardiac Surgery

NCT02963883

Cardiac Surgery

COMPLETED NA

Restrictive Transfusion StratEgy Adjusted by SvO2 During Cardiac Surgery

NCT05740059

Cardiac Surgery Cardiopulmonary Bypass

COMPLETED NA

Perioperative Transfusion Strategies in Adult Congenital Heart Disease Patients Undergoing Cardiac Surgery

NCT04973514

Congenital Heart Disease Cardiac Surgery Blood Transfusion +1 more

UNKNOWN

Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course

NCT03740438

Surgical Blood Loss Surgery Perioperative/Postoperative Complications

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Determine a bleeding threshold by measuring the blood volume in ml / kg / h collected in the drainage system to define moderate bleeding postoperative cardiac surgery and define the population.

Secondary objectives:

To evaluate the kinetics of moderate SPORT and its impact on anemia and postoperative transfusion.

To evaluate the prognostic impact of the SPO moderate in terms of post-operative complications.

Determine predictors of moderate SPO.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients in the postoperative intensive care in cardiac surgery

Exclusion Criteria

* Patients who received a heart transplant, a heart surgery beating, cardiac support establishment of long duration, or have a disease that alters the coagulation.

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No